ATE201994T1 - Mittel und methoden zur verbesserung der keratinocytenadhäsion an der haut - Google Patents
Mittel und methoden zur verbesserung der keratinocytenadhäsion an der hautInfo
- Publication number
- ATE201994T1 ATE201994T1 AT93920392T AT93920392T ATE201994T1 AT E201994 T1 ATE201994 T1 AT E201994T1 AT 93920392 T AT93920392 T AT 93920392T AT 93920392 T AT93920392 T AT 93920392T AT E201994 T1 ATE201994 T1 AT E201994T1
- Authority
- AT
- Austria
- Prior art keywords
- kda
- laminin
- kalinin
- methods
- adhesion
- Prior art date
Links
- 210000002510 keratinocyte Anatomy 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 210000003491 skin Anatomy 0.000 title 1
- 108010028309 kalinin Proteins 0.000 abstract 4
- YTOPFCCWCSOHFV-UHFFFAOYSA-N 2,6-dimethyl-4-tridecylmorpholine Chemical compound CCCCCCCCCCCCCN1CC(C)OC(C)C1 YTOPFCCWCSOHFV-UHFFFAOYSA-N 0.000 abstract 3
- 239000012634 fragment Substances 0.000 abstract 3
- 210000004027 cell Anatomy 0.000 abstract 1
- 210000004207 dermis Anatomy 0.000 abstract 1
- 210000005175 epidermal keratinocyte Anatomy 0.000 abstract 1
- 239000000758 substrate Substances 0.000 abstract 1
- 238000001262 western blot Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
- C12N5/0629—Keratinocytes; Whole skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/60—Materials for use in artificial skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0068—General culture methods using substrates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/50—Cell markers; Cell surface determinants
- C12N2501/58—Adhesion molecules, e.g. ICAM, VCAM, CD18 (ligand), CD11 (ligand), CD49 (ligand)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/52—Fibronectin; Laminin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Transplantation (AREA)
- General Engineering & Computer Science (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Developmental Biology & Embryology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Cosmetics (AREA)
- Adhesives Or Adhesive Processes (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/936,850 US5352668A (en) | 1991-03-26 | 1992-08-28 | Product and method for improving keratinocyte adhesion to the dermis |
US96697492A | 1992-10-26 | 1992-10-26 | |
PCT/US1993/008108 WO1994005316A1 (en) | 1992-08-28 | 1993-08-27 | Products and methods for improving keratinocyte adhesion to the dermis |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE201994T1 true ATE201994T1 (de) | 2001-06-15 |
Family
ID=27130093
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT93920392T ATE201994T1 (de) | 1992-08-28 | 1993-08-27 | Mittel und methoden zur verbesserung der keratinocytenadhäsion an der haut |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0675728B1 (de) |
JP (1) | JPH08502733A (de) |
AT (1) | ATE201994T1 (de) |
AU (1) | AU691788B2 (de) |
CA (1) | CA2143644A1 (de) |
DE (1) | DE69330352T2 (de) |
WO (1) | WO1994005316A1 (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0579742A4 (en) * | 1991-03-26 | 1994-07-13 | Oregon State | Product and method for improving keratinocyte adhesion to the dermis |
US5585267A (en) * | 1993-04-05 | 1996-12-17 | Desmos, Inc. | Cellular attachment to trans-epithelial appliances |
USRE36844E (en) * | 1993-04-05 | 2000-08-29 | Desmos Incorporated | Cellular attachment to trans-epithelial appliances |
US5510263A (en) * | 1993-04-05 | 1996-04-23 | Desmos, Inc. | Growth of pancreatic islet-like cell clusters |
US5422264A (en) * | 1993-11-12 | 1995-06-06 | Desmos, Inc. | Soluble factor stimulation of attachment and hemidesmosome assembly in epithelial cells |
US5541106A (en) * | 1993-04-05 | 1996-07-30 | Desmos, Inc. | Cell matrix stimulated attachment and hemidesmosome assembly |
US5681587A (en) * | 1995-10-06 | 1997-10-28 | Desmos, Inc. | Growth of adult pancreatic islet cells |
US5672361A (en) * | 1996-03-29 | 1997-09-30 | Desmos, Inc. | Laminin 5 for growth of pancreatic islet cells |
EP0889743A1 (de) * | 1996-03-29 | 1999-01-13 | Desmos, Inc. | Fixierung von zellen an transepithelgeräte |
US5770448A (en) * | 1996-03-29 | 1998-06-23 | Northwestern University | Human epithelial cell matrix and uses therefor |
JP2000513220A (ja) * | 1996-06-05 | 2000-10-10 | ザ ジェネラル ホスピタル コーポレイション | ラミニン―5及び基底膜構造の形成 |
US5760179A (en) * | 1996-06-10 | 1998-06-02 | Desmos, Inc. | Purification of soluble laminin 5 |
US6294356B1 (en) | 1998-01-16 | 2001-09-25 | Northwestern University | Methods and materials for making and using laminin-5 |
US6703363B1 (en) | 1999-04-30 | 2004-03-09 | Biostratum, Inc. | Recombinant laminin 5 |
JP2002542824A (ja) * | 1999-04-30 | 2002-12-17 | バイオストラタム インコーポレイテッド | 組換えラミニン5 |
CN1321660A (zh) * | 2000-04-29 | 2001-11-14 | 上海博德基因开发有限公司 | 一种新的多肽——人层粘连蛋白b2链13和编码这种多肽的多核苷酸 |
-
1993
- 1993-08-27 WO PCT/US1993/008108 patent/WO1994005316A1/en active IP Right Grant
- 1993-08-27 JP JP6507342A patent/JPH08502733A/ja not_active Ceased
- 1993-08-27 AT AT93920392T patent/ATE201994T1/de active
- 1993-08-27 DE DE69330352T patent/DE69330352T2/de not_active Expired - Fee Related
- 1993-08-27 EP EP93920392A patent/EP0675728B1/de not_active Expired - Lifetime
- 1993-08-27 AU AU50954/93A patent/AU691788B2/en not_active Ceased
- 1993-08-27 CA CA002143644A patent/CA2143644A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU691788B2 (en) | 1998-05-28 |
AU5095493A (en) | 1994-03-29 |
JPH08502733A (ja) | 1996-03-26 |
WO1994005316A1 (en) | 1994-03-17 |
EP0675728B1 (de) | 2001-06-13 |
DE69330352T2 (de) | 2002-01-03 |
EP0675728A1 (de) | 1995-10-11 |
CA2143644A1 (en) | 1994-03-17 |
EP0675728A4 (de) | 1996-07-17 |
DE69330352D1 (de) | 2001-07-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE201994T1 (de) | Mittel und methoden zur verbesserung der keratinocytenadhäsion an der haut | |
ATE201416T1 (de) | Varianten von adhäsionsmoleküle für blutplättchen | |
CA2106955A1 (en) | Product and method for improving keratinocyte adhesion to the dermis | |
ZA975851B (en) | Hepatocyte grown factor receptor agonists and uses thereof | |
AU5055593A (en) | Antibodies specific for HIV | |
ATE368054T1 (de) | Verbindungen und methoden zur modulierung von occludin-abhängiger gewebepermeabilität | |
ATE352617T1 (de) | Lösliche polypeptidfraktionen des lag-3-proteins; verfahren zur herstellung; therapeutische zusamensetzung; antiidiotypischer antikörper | |
ATE403680T1 (de) | Herstellung tetravalenter antikörper | |
HUP9900422A1 (hu) | Új fehérjék és eljárások a fehérjék előállítására | |
LU91237I2 (fr) | Palifermin et ses dérivés pharmaceutiquement acceptables (kepivance) | |
DK289285D0 (da) | Thymopentin analoge | |
ATE199095T1 (de) | Heparin bindendes mitogen mit homologie zum epidermis wachstumsfaktor (egf) | |
ES2090052T3 (es) | Anticuerpos monoclonales (mak) contra antigenos asociados a tumores, su preparacion y uso. | |
AU5229498A (en) | Mutants of the lag-3 proteins, products for the expression of these mutants and use | |
FI931393A0 (fi) | Peptider foer anvaendning vid vaccinering och induktion av neutraliserande motkroppar mot humant immunbristvirus | |
DE3854300D1 (de) | Lymphocyteninhibierung durch hla-peptide. | |
ATE262537T1 (de) | Proliferationsinhibitor von endothellzellen und dessen verwendung | |
DE69505804T2 (de) | Afamin: ein menschliches serum albumin ähnliches protein | |
DE69023648D1 (de) | Herstellung eines virus und reinigung von virenüberzugsproteinen zur impfstoffverwendung. | |
GR3029483T3 (en) | Antibodies against t-cells as therapeutics | |
AU1540795A (en) | Diagnosis and treatment of infections due to streptococci and enterococci | |
WO1998019160A3 (de) | VERFAHREN ZUR INDIREKTEN BESTIMMUNG DER TYP I INTERFERON-PRODUKTION IN VIVO MITTELS ANTIKÖRPER GEGEN HUMANE Mx-PROTEINE SOWIE ANTIKÖRPER HIERZU | |
ATE58397T1 (de) | Monoklonaler antikoerper geeignet zur spezifischen unterscheidung von humanen hepatokarzinomzellen. | |
ES2101694T3 (es) | Expresion de edulcorantes proteinicos en levadura. | |
WO1995021916A3 (en) | Pp32: a newly identified cd45-associated protein |